Fig 1.
Sufficient component cause models (SCCMs) of ADL episodes among patients with lymphatic filariasis.
Each SCCM represents a sufficient cause, which contains a minimal set of conditions that result in the outcome of interest. Each piece of the pie represents a risk factor for the outcome and is defined as a component cause. Each pie is defined as a sufficient cause.
Table 1.
Demographic and clinical characteristics of lymphedema patients in Léogâne, Haiti.
N = 41 patients with 52 ADL episodes.
Fig 2.
Proportion of ADL episodes with an antibody response for filarial, bacterial, and fungal antigens among a cohort of 52 paired serum samples from patients enrolled in a lymphedema program in Léogâne, Haiti.
Filarial antigens: BpG1, BpG2, BpG3, and BpG4. Bacterial antigens: Pseudomonas, SEB, SPEA, SPEB, SLO, and Strep A. Fungal antigens: Candida and Trichophyton. All antibody change levels represent a 100 percent (two-fold) increase in antibody titer from the ADL to convalescent time point.
Table 2.
Serum antibody levels stratified by sample time point as determined by ELISA tests among lymphedema patients in Léogâne, Haiti.
All values are in arbitrary units. N = 52 paired samples.